EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Post-Translational Control of PD-L1 in Cancer Immunity and Immunotherapy Resistance

Miaomiao Li iD, Jiahui Li, Wentong Tian, Jiachang Tao, Ziyi Fu, Yaoxin Gao

ImmunoTargets and Therapy · 2026-10 · Volume 15 · 1-31

DOI: 10.2147/itt.s637720 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ImmunoTargets and Therapy, 2026-10. Verfasst von Miaomiao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PD-L1cancer immunotherapyimmune checkpointpost-translational modificationtumor immune evasion

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
  • Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Department of Radiation Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
  • Cell Research and Transformation Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, People's Republic of China.

ORCID-Profile: Miaomiao Li

Zitieren

APA

Li, M., Li, J., Tian, W., Tao, J., Fu, Z., & Gao, Y. (2026). Post-Translational Control of PD-L1 in Cancer Immunity and Immunotherapy Resistance. ImmunoTargets and Therapy, Volume 15, 1-31. https://doi.org/10.2147/itt.s637720

Vancouver

Li M, Li J, Tian W, Tao J, Fu Z, Gao Y. Post-Translational Control of PD-L1 in Cancer Immunity and Immunotherapy Resistance. ImmunoTargets and Therapy. 2026;Volume 15:1-31. doi:10.2147/itt.s637720

BibTeX
@article{Li2026,
  author = {Li, Miaomiao and Li, Jiahui and Tian, Wentong and Tao, Jiachang and Fu, Ziyi and Gao, Yaoxin},
  title = {Post-Translational Control of PD-L1 in Cancer Immunity and Immunotherapy Resistance},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--31},
  doi = {10.2147/itt.s637720}
}
Kostenlos starten →